Harrow Health Inc. (HROW)

HROW trades at $47.1, 38.5% above the near-term max pain of $34 expiring Oct 17, 2025 (18 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($7.5-$40), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for HROW shows a downward trend from 40 to 7.5, indicating bearish sentiment or hedging activity. The 114% spread signals divergent expectations across timeframes. Most levels below 47.1 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.